Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

OFIX

Orthofix Medical Inc

May 02 • 04:00PM ET

13.24

Dollar change +0.22
Percentage change 1.65	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN IHI SCHA VTWO VHT IWC PRFZ

Index	RUT	P/E	-	EPS (ttm)	-4.15	Insider Own	4.08%	Shs Outstand	37.16M	Perf Week	1.07%
Market Cap	495.31M	Forward P/E	-	EPS next Y	-0.81	Insider Trans	0.00%	Shs Float	35.88M	Perf Month	-4.47%
Income	-151.40M	PEG	-	EPS next Q	-0.51	Inst Own	94.92%	Short Float	10.53%	Perf Quarter	-7.22%
Sales	746.64M	P/S	0.66	EPS this Y	64.20%	Inst Trans	-0.56%	Short Ratio	10.61	Perf Half Y	19.93%
Book/sh	16.11	P/B	0.82	EPS next Y	45.08%	ROA	-21.88%	Short Interest	3.78M	Perf Year	-28.70%
Cash/sh	1.01	P/C	13.12	EPS next 5Y	9.40%	ROE	-32.36%	52W Range	9.57 - 21.60	Perf YTD	-1.78%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-20.81%	52W High	-38.70%	Beta	1.06
Dividend TTM	-	Quick Ratio	1.20	Sales past 5Y	13.08%	Gross Margin	62.80%	52W Low	38.28%	ATR (14)	0.46
Dividend Ex-Date	-	Current Ratio	2.54	EPS Y/Y TTM	-321.91%	Oper. Margin	-18.99%	RSI (14)	47.33	Volatility	2.48% 3.18%
Employees	1634	Debt/Eq	0.22	Sales Y/Y TTM	62.06%	Profit Margin	-20.28%	Recom	2.60	Target Price	18.47
Option/Short	Yes / Yes	LT Debt/Eq	0.22	EPS Q/Q	-70.05%	Payout	-	Rel Volume	0.46	Prev Close	13.02
Sales Surprise	0.06%	EPS Surprise	-1080.07%	Sales Q/Q	63.97%	Earnings	May 07 BMO	Avg Volume	356.10K	Price	13.24
SMA20	-1.45%	SMA50	-2.73%	SMA200	-6.62%	Trades		Volume	165,520	Change	1.65%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-20-23	Initiated	ROTH MKM	Neutral	$12
Sep-12-23	Downgrade	Stifel	Buy → Hold
Sep-12-23	Downgrade	BTIG Research	Buy → Neutral
Jul-19-23	Resumed	BTIG Research	Buy	$27
Mar-04-22	Upgrade	Stifel	Hold → Buy	$41 → $45
Oct-20-20	Initiated	Stifel	Hold	$39
Oct-29-19	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$71 → $48
Jun-01-18	Initiated	Cantor Fitzgerald	Overweight
Jun-21-17	Initiated	BTIG Research	Buy	$52
Jun-14-17	Initiated	Ladenburg Thalmann	Buy	$53.25
May-23-17	Initiated	SunTrust	Buy	$49
Jul-10-15	Initiated	Sidoti	Buy
May-09-13	Downgrade	Mizuho	Buy → Neutral	$45 → $28
Jan-08-13	Reiterated	Mizuho	Buy	$47 → $45
Jun-21-10	Initiated	Boenning & Scattergood	Outperform	$45
Mar-09-10	Reiterated	Jefferies & Co	Buy	$38 → $40
Feb-18-10	Upgrade	Susquehanna Financial	Neutral → Positive
Jan-22-10	Initiated	Jefferies & Co	Buy	$37
Nov-03-09	Upgrade	Wells Fargo	Underperform → Market Perform
Jul-31-09	Upgrade	Thomas Weisel	Market Weight → Overweight

Show Previous Ratings

Apr-26-24 06:37AM	Marriott Vacations, Carrols Restaurant Group, and More Stocks See Action From Activist Investors (Barrons.com)
Apr-23-24 07:00AM	Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024 (Business Wire)
Apr-16-24 07:00AM	Orthofix Names Andres Cedron as New Chief Legal Officer (Business Wire)
Mar-18-24 07:00AM	Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer (Business Wire)
Mar-12-24 11:01AM	Orthofix (OFIX) Q4 Earnings Beat Estimates, Gross Margin Up (Zacks)
01:40PM	Loading…
Mar-07-24 01:40PM	Orthofix Medical Inc (OFIX) Reports Significant Sales Growth and Improved EBITDA in Q4 and Full ... (GuruFocus.com)
09:53AM	Orthofix Medical Inc. (NASDAQ:OFIX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-06-24 08:21AM	Q4 2023 Orthofix Medical Inc Earnings Call (Thomson Reuters StreetEvents) +8.69%
Mar-05-24 10:52PM	OFIX Stock Earnings: Orthofix Medical Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
04:42PM	Orthofix: Q4 Earnings Snapshot (Associated Press Finance)
04:03PM	Orthofix Reports Fourth Quarter and Full Year 2023 Results (Business Wire)
Feb-29-24 07:00AM	Orthofix Announces New President for Bone Growth Therapies Business (Business Wire)
Feb-21-24 07:00AM	Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024 (Business Wire)
Jan-18-24 07:00AM	Orthofix Announces Commercial Partnership with MRIguidance (Business Wire)
Jan-16-24 07:00AM	Julie Andrews Begins as New Chief Financial Officer at Orthofix (Business Wire)
08:00AM	Loading…
Jan-09-24 08:00AM	Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results (Business Wire) +9.78%
Jan-08-24 07:00AM	Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer (Business Wire)
Dec-27-23 08:45AM	Orthofix (OFIX) Releases New Data for Spinal Fusion Procedures (Zacks)
Dec-21-23 07:00AM	Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis (Business Wire)
Dec-12-23 07:00AM	Orthofix Announces Agreement with Engine Capital and Appointment of Three New Independent Directors to Further Advance Position as Leading Global Spine and Orthopedics Company (Business Wire)
Dec-11-23 09:55AM	Wall Street Analysts Believe Orthofix (OFIX) Could Rally 72.19%: Here's is How to Trade (Zacks)
Dec-01-23 06:16PM	Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
Nov-29-23 12:21PM	Lowey Dannenberg, P.C. is Investigating Orthofix Medical Inc. (NASDAQ: OFIX) for Potential Breaches of Fiduciary Duty by Its Board of Directors (GlobeNewswire)
07:00AM	Orthofix Announces Publication in The Spine Journal of Five-Year Data for the M6-C Artificial Cervical Disc (Business Wire)
Nov-28-23 11:30AM	Orthofix hires new CEO, 2 months after former leaders ousted (MedTech Dive)
07:00AM	Orthofix Names Massimo Calafiore as President and Chief Executive Officer (Business Wire)
Nov-27-23 10:48AM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm's Attorneys, Firm Investigating Events Leading to Termination of Senior Management (GlobeNewswire)
Nov-24-23 12:28PM	Orthofix (OFIX) Q3 Earnings Top Estimates, 2023 Sales View Cut (Zacks)
Nov-23-23 09:55AM	Does Orthofix (OFIX) Have the Potential to Rally 78.73% as Wall Street Analysts Expect? (Zacks)
Nov-21-23 06:30PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm's Attorneys, Firm Investigating Events Leading to Termination of Senior Management (GlobeNewswire)
09:00AM	Loading…
Nov-13-23 09:00AM	ORTHOFIX SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options (PR Newswire)
Nov-09-23 01:43PM	Orthofix Medical Inc. (NASDAQ:OFIX) Q3 2023 Earnings Call Transcript (Insider Monkey) -10.37%
Nov-08-23 05:36PM	Orthofix: Q3 Earnings Snapshot (Associated Press Finance)
04:07PM	Orthofix Reports Third Quarter 2023 Results (Business Wire)
09:00AM	ORTHOFIX SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options (PR Newswire)
Nov-07-23 03:59PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm's Attorneys, Firm Investigating Events Leading to Termination of Senior Management (GlobeNewswire)
Nov-06-23 07:00AM	Orthofix Announces Full Commercial Launch of the WaveForm L Interbody System for Lateral Lumbar Fusion Procedures (Business Wire)
Nov-02-23 10:00AM	Hologic (HOLX) Earnings Expected to Grow: Should You Buy? (Zacks) +5.98%
Nov-01-23 10:01AM	Orthofix (OFIX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-31-23 01:48PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm's Attorneys, Firm Investigating Possible Securities Law Violations (GlobeNewswire)
Oct-29-23 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Orthofix, Dollar, and Clorox and Encourages Investors to Contact the Firm (GlobeNewswire)
Oct-23-23 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Viasat, Veradigm, and Orthofix and Encourages Investors to Contact the Firm (GlobeNewswire)
03:54PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm's Attorneys, Firm Investigating Possible Securities Law Violations (GlobeNewswire)
Oct-18-23 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Scynexis and Encourages Investors to Contact the Firm (GlobeNewswire) -6.66%
07:00AM	Orthofix Schedules Third Quarter Earnings Release and Conference Call for November 8, 2023 (Business Wire)
Oct-17-23 08:33AM	Orthofix (OFIX) Secures FDA 510k Clearance for OsteoCove Graft (Zacks)
Oct-13-23 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Dollar and Encourages Investors to Contact the Firm (GlobeNewswire)
08:40PM	Orthofix Medical Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
08:23AM	Orthofix (OFIX) Soars 6.4%: Is Further Upside Left in the Stock? (Zacks)
Oct-12-23 09:10AM	Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims against Orthofix Medical Inc. (PR Newswire) +6.41%
07:00AM	Orthofix Announces 510k Clearance and Full Commercial Launch of OsteoCove, an Advanced Bioactive Synthetic Graft for use in Spine and Orthopedic Procedures (Business Wire)
Oct-09-23 05:25PM	Orthofix Medical Investors: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
01:48PM	Hagens Berman Encourages Orthofix Medical (OFIX) Shareholders to Contact the Firm (GlobeNewswire)
Oct-08-23 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Dollar and Encourages Investors to Contact the Firm (GlobeNewswire)
Oct-06-23 09:13AM	Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims against Orthofix Medical Inc. (PR Newswire)
Oct-02-23 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Orthofix, and Scynexis and Encourages Investors to Contact the Firm (GlobeNewswire)
Sep-27-23 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating FMC, and Orthofix and Encourages Investors to Contact the Firm (GlobeNewswire)
Sep-21-23 09:22AM	Orthofix (OFIX) Unveils Gemini System, Advances in Trauma Wing (Zacks)
Sep-20-23 07:00AM	Orthofix Announces First Patient Procedures and Full Commercial Launch of the Galaxy Fixation Gemini System and Expanded Sterile Kit Offerings for Orthopedic Trauma Procedures (Business Wire)
Sep-15-23 01:03PM	Director James Hinrichs Acquires 7,500 Shares of Orthofix Medical Inc (GuruFocus.com)
Sep-12-23 02:41PM	Why Shares of Orthofix Medical Are Plummeting on Tuesday (Motley Fool) -30.17%
07:03AM	Orthofix Announces Leadership Changes (Business Wire)
Sep-01-23 09:55AM	Should You Buy Orthofix (OFIX) After Golden Cross? (Zacks)
Aug-31-23 08:00AM	Orthofix to Participate in Morgan Stanley Healthcare Conference (Business Wire)
Aug-29-23 09:40AM	Orthofix's (OFIX) New Launch to Benefit the MIS Spine Market (Zacks)
Aug-28-23 07:00AM	Orthofix Announces First Cases and Full Commercial Launch of the 7D FLASH Navigation System Percutaneous Module 2.0 for Minimally Invasive Surgery (Business Wire) +5.23%
Aug-23-23 07:00AM	Orthofix Medical to Host Investor Day on September 20, 2023 (Business Wire)
Aug-08-23 07:15PM	Orthofix (OFIX) Q2 Earnings and Revenues Surpass Estimates (Zacks)
06:17PM	Orthofix: Q2 Earnings Snapshot (AP Finance)
04:08PM	Orthofix Reports Second Quarter 2023 Results and Raises Revenue and Adjusted EBITDA Guidance (Business Wire)
Jul-25-23 07:00AM	Orthofix Schedules Second Quarter Earnings Release and Conference Call for August 8, 2023, and Announces Participation in Upcoming Investor Conference (Business Wire)
Jun-28-23 07:00AM	Orthofix Introduces New Phantom and Tornado Hinges for TrueLok Ring Fixation Systems (Business Wire)
Jun-21-23 08:00PM	OFIX: What does Argus have to say about OFIX? (Argus Research)
Jun-20-23 04:01PM	Orthofix Announces Changes to Board of Directors (Business Wire)
11:39AM	Orthofix (OFIX) Advances in ALIF Procedure With New Launch (Zacks)
Jun-19-23 07:00AM	Orthofix Announces the Full Commercial Launch of WaveForm A 3D Printed Anterior Lumbar Interbody (Business Wire)
Jun-01-23 07:00AM	Orthofix Announces First Presentation of Seven-Year Outcome Data for the M6-C Artificial Cervical Disc With Other Clinical and Scientific Abstracts at the ISASS Annual Meeting (Business Wire)
May-09-23 05:15PM	Orthofix (OFIX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:10PM	Orthofix: Q1 Earnings Snapshot (AP Finance)
04:01PM	Orthofix Reports First Quarter 2023 Results (Business Wire)
May-04-23 07:00AM	MedTech Breakthrough Recognizes STIM onTrack for Bone Growth Therapy as Best Patient Engagement Mobile App (Business Wire)
Apr-26-23 08:00PM	OFIX: Rating decreased to a SELL (Argus Research)
04:01PM	Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 9, 2023 (Business Wire)
Apr-25-23 07:00AM	Orthofix Expands Solutions for Minimally Invasive Spine Procedures with the Full Commercial Launch of Two Access Retractor Systems (Business Wire)
Apr-06-23 09:05AM	Boston Scientific (BSX) Hits 52-Week High: What's Driving It? (Zacks)
Apr-04-23 08:43AM	Here's Why You Should Retain Amedisys (AMED) Stock for Now (Zacks)
Apr-03-23 08:53AM	Bruker Corporation (BRKR) Hits 52-Week High: What's Driving It? (Zacks)
Mar-10-23 08:26AM	Orthofix (OFIX) Q4 Earnings Beat Estimates, Gross Margin Dips (Zacks)
Mar-08-23 10:08AM	Orthofix (OFIX) Progresses With Limb-Lengthening Device (Zacks)
07:00AM	Orthofix Medical Inc. (NASDAQ:OFIX) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-07-23 08:03AM	Q4 2022 Orthofix Medical Inc Earnings Call (Thomson Reuters StreetEvents)
07:00AM	Orthofix Announces More Than 5,000 Fitbone Intramedullary Limb-lengthening Devices Implanted Worldwide to Date and Over Twenty Years of Clinical History (Business Wire)
Mar-06-23 04:01PM	Orthofix Medical Reports Orthofix and SeaSpine Fourth Quarter and Full-Year 2022 Results (Business Wire)
Mar-03-23 07:00AM	Orthofix Medical to Hold Analyst Teach-In Meeting on March 13, 2023 (Business Wire)
Feb-22-23 04:05PM	Orthofix Medical to Present at Canaccord Genuity 2023 Musculoskeletal Conference (Business Wire)
Feb-21-23 04:05PM	Orthofix Medical Schedules Fourth Quarter Earnings Release and Conference Call for March 6, 2023 (Business Wire)
Jan-26-23 07:00AM	Orthofix Announces Full Commercial Launch and First Patient Cases of Mariner Deformity System (Business Wire)
Jan-14-23 03:14PM	15 Largest Orthopedic Companies in the World (Insider Monkey)
Jan-09-23 07:00AM	Orthofix Medical Inc. Announces Preliminary SeaSpine and Orthofix 2022 Fourth Quarter and Full-Year Net Sales Results (Business Wire) -6.60%
Jan-04-23 04:01PM	Orthofix and SeaSpine Announce Completion of Merger of Equals to Create a Leading Global Spine and Orthopedics Company (Business Wire) +6.60%

Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kenny Kevin J.	President of Global Spine	Jan 08 '24	Option Exercise	0.00	5,959	0	147,321	Jan 10 04:55 PM
Hinrichs James F.	Director	Sep 14 '23	Buy	13.47	7,500	101,025	86,153	Sep 14 05:15 PM
Kenny Kevin J.	President of Global Spine	May 26 '23	Sale	19.00	3,876	73,644	142,431	May 26 05:50 PM
Kenny Kevin J.	President of Global Spine	May 24 '23	Sale	19.00	4,367	82,973	146,307	May 26 05:50 PM

Open in Screener

OM

Outset Medical Inc

May 02 • 04:00PM ET

3.00

Dollar change +0.15
Percentage change 5.26	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWO SCHA VTWO VHT PRFZ DFAS VTWG

Index	RUT	P/E	-	EPS (ttm)	-3.49	Insider Own	8.20%	Shs Outstand	50.32M	Perf Week	26.05%
Market Cap	151.53M	Forward P/E	-	EPS next Y	-1.80	Insider Trans	-2.27%	Shs Float	46.36M	Perf Month	47.78%
Income	-172.80M	PEG	-	EPS next Q	-0.55	Inst Own	106.55%	Short Float	18.51%	Perf Quarter	0.67%
Sales	130.38M	P/S	1.16	EPS this Y	22.82%	Inst Trans	-4.70%	Short Ratio	8.85	Perf Half Y	-15.25%
Book/sh	2.44	P/B	1.23	EPS next Y	13.82%	ROA	-48.41%	Short Interest	8.58M	Perf Year	-84.49%
Cash/sh	4.03	P/C	0.75	EPS next 5Y	-	ROE	-93.69%	52W Range	1.92 - 24.13	Perf YTD	-44.55%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-15.08%	ROI	-67.11%	52W High	-87.57%	Beta	1.82
Dividend TTM	-	Quick Ratio	4.37	Sales past 5Y	202.67%	Gross Margin	22.24%	52W Low	56.25%	ATR (14)	0.23
Dividend Ex-Date	-	Current Ratio	5.26	EPS Y/Y TTM	-2.89%	Oper. Margin	-130.22%	RSI (14)	66.21	Volatility	9.03% 9.88%
Employees	480	Debt/Eq	1.11	Sales Y/Y TTM	13.00%	Profit Margin	-132.54%	Recom	2.25	Target Price	5.79
Option/Short	Yes / Yes	LT Debt/Eq	1.10	EPS Q/Q	10.34%	Payout	-	Rel Volume	1.05	Prev Close	2.85
Sales Surprise	0.00%	EPS Surprise	7.81%	Sales Q/Q	-4.69%	Earnings	May 08 AMC	Avg Volume	969.40K	Price	3.00
SMA20	28.59%	SMA50	19.07%	SMA200	-56.96%	Trades		Volume	1,016,699	Change	5.26%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-08-24	Initiated	BTIG Research	Buy	$6
Apr-05-24	Upgrade	CL King	Neutral → Buy	$6
Jan-12-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$14 → $6
Oct-13-23	Downgrade	BofA Securities	Buy → Underperform	$32 → $3
Aug-17-23	Initiated	CL King	Neutral
Nov-11-22	Initiated	RBC Capital Mkts	Outperform	$23
Jul-14-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$48 → $20
Mar-02-22	Resumed	BofA Securities	Buy	$50
Feb-17-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$50
Aug-18-21	Initiated	Cowen	Outperform	$70
Apr-19-21	Initiated	Wells Fargo	Overweight	$63
Dec-16-20	Initiated	Oppenheimer	Perform
Oct-12-20	Initiated	SVB Leerink	Mkt Perform	$60
Oct-12-20	Initiated	Stifel	Buy	$54
Oct-12-20	Initiated	Morgan Stanley	Equal-Weight	$48
Oct-12-20	Initiated	Goldman	Buy	$54
Oct-12-20	Initiated	BofA Securities	Buy	$54
Oct-12-20	Initiated	Barclays	Overweight

Show Previous Ratings

May-01-24 04:30PM	Outset Medical to Present at Upcoming Investor Conferences (Business Wire) +12.65%
Apr-19-24 08:30AM	Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 (Business Wire)
Apr-18-24 01:36PM	Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis (Zacks)
Apr-17-24 08:30AM	Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S. (Business Wire)
Apr-15-24 08:30AM	Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care (Business Wire)
04:02PM	Loading…
Mar-13-24 04:02PM	Outset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of Directors (Business Wire)
Mar-05-24 03:34PM	Why Dialysis Stocks Are up Today (The Wall Street Journal)
Feb-26-24 09:00AM	Outset Medical to Present at the 44th Annual TD Cowen Health Care Conference (Business Wire)
Feb-22-24 10:51AM	Outset Medical, Inc. (NASDAQ:OM) Q4 2023 Earnings Call Transcript (Insider Monkey) +6.23%
07:10AM	Q4 2023 Outset Medical Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-21-24 04:49PM	Outset Medical Inc (OM) Reports Mixed Q4 and Full Year 2023 Results (GuruFocus.com)
04:05PM	Outset Medical Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-20-24 04:25PM	ROLLINS, INC. ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS (PR Newswire)
Feb-05-24 10:00AM	Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: Should You Buy? (Zacks) +5.76%
08:30AM	Outset Medical to Report Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, February 21, 2024 (Business Wire)
08:30AM	Loading…
Jan-08-24 08:30AM	Outset Medical Reports Unaudited Fourth Quarter and 2023 Revenue, Provides 2024 Revenue and Non-GAAP Gross Margin Guidance (Business Wire)
Jan-03-24 08:30AM	Outset Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Nov-29-23 04:05PM	Outset Medical to Present at BofA Home Care Conference (Business Wire) +5.70%
Nov-25-23 11:43AM	5 Struggling Stocks to Buy at a Discount (Motley Fool)
Nov-23-23 06:30AM	2 of the Cheapest Stocks I Own (Motley Fool)
Nov-16-23 02:46PM	Outset Medical (OM) Investigated for Possible Securities Law Violations: Hagens Berman, National Trial Attorneys, Encourages Investors with Losses to Contact the Firm's Attorneys (GlobeNewswire)
Nov-09-23 04:05PM	Outset Medical to Present at Upcoming Investor Conferences (Business Wire)
Nov-07-23 04:31PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Outset Medical (OM) Shareholders with Losses to Contact its Attorneys, Firm Investigating Possible Securities Law Violations (GlobeNewswire)
04:05PM	Outset Medical Reports Third Quarter 2023 Financial Results (Business Wire)
Nov-02-23 10:00AM	Analysts Estimate Olink Holding AB (publ) Sponsored ADR (OLK) to Report a Decline in Earnings: What to Look Out for (Zacks) +7.18%
09:35AM	After Plunging -62.36% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical, Inc. (OM) (Zacks)
Nov-01-23 09:00AM	New Data Insights Unveiled at ASN Kidney Week 2023 Point to the Impact of the Tablo Hemodialysis System on Equitable Kidney Care (Business Wire) +6.21%
Oct-31-23 02:00PM	Outset Medical (OM) Investigated for Possible Securities Law Violations: Hagens Berman, National Trial Attorneys, Encourages Investors with Losses to Contact the Firm (GlobeNewswire) +15.31%
10:01AM	Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-30-23 04:05PM	Outset Medical to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023 (Business Wire)
11:42AM	Loading…
Oct-27-23 11:42AM	Hagens Berman Encourages Outset Medical (OM) Shareholders with Losses to Contact its Attorneys, Firm Investigating Possible Securities Law Violations (GlobeNewswire)
Oct-19-23 12:31PM	Outset Medical (PM) Investigated for Possible Securities Law Violations, Hagens Berman Encourages Investors with Losses to Contact its Attorneys (GlobeNewswire) -6.67%
Oct-17-23 05:36PM	Outset Medical, Inc.: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
09:35AM	Down -68.16% in 4 Weeks, Here's Why You Should You Buy the Dip in Outset Medical, Inc. (OM) (Zacks)
Oct-16-23 08:14AM	Outset Medical, Inc. (NASDAQ:OM) Q3 2023 Earnings Call Transcript (Insider Monkey) +15.04%
Oct-13-23 07:21PM	Outset Medical stock nosedives due to FDA warning letter headwinds Hagens Berman (GlobeNewswire) -49.93%
09:50AM	Netflix downgraded, Applied Materials upgraded: Wall Street's top analyst calls (The Fly)
Oct-12-23 04:05PM	Outset Medical Reports Preliminary Third Quarter 2023 Financial Results (Business Wire) -11.33%
Aug-29-23 04:05PM	Outset Medical to Present at the Morgan Stanley 21st Annual Global Healthcare Conference (Business Wire)
Aug-14-23 09:24PM	Investors Look at Apple, Amazon, and More (Motley Fool)
Aug-02-23 05:55PM	Outset Medical, Inc. (OM) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Outset Medical Reports Second Quarter 2023 Financial Results (Business Wire)
Jul-13-23 08:30AM	Outset Medical to Report Second Quarter 2023 Financial Results on Wednesday, August 2, 2023 (Business Wire)
Jul-10-23 01:09PM	Why Shares of Outset Medical Are Down Monday (Motley Fool) -5.87%
10:48AM	Shareholders in These 2 Stocks Got Nasty Surprises Monday (Motley Fool)
Jun-15-23 06:56AM	Getting In Cheap On Outset Medical, Inc. (NASDAQ:OM) Might Be Difficult (Simply Wall St.)
Jun-06-23 04:05PM	Outset Medical to Present at Goldman Sachs 44th Annual Global Healthcare Conference (Business Wire) +6.06%
May-30-23 07:30AM	The Ultimate Growth Stocks to Buy With $1,400 Right Now (Motley Fool)
May-05-23 06:14AM	Outset Medical First Quarter 2023 Earnings: Beats Expectations (Simply Wall St.)
May-04-23 09:13AM	Q1 2023 Outset Medical Inc Earnings Call (Thomson Reuters StreetEvents)
May-03-23 06:35PM	Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +5.02%
04:05PM	Outset Medical Reports First Quarter 2023 Financial Results (Business Wire)
Apr-30-23 05:50AM	Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade. (Motley Fool)
Apr-25-23 08:30AM	Outset Medical to Present at Upcoming Investor Conferences (Business Wire)
Apr-23-23 07:03AM	This Could Be the Best Growth Stock Under $20 on the Market Right Now (Motley Fool)
Apr-12-23 09:05AM	Outset Medical to Present Research Highlighting Home Hemodialysis Success for Underserved Populations at National Kidney Foundation Spring Clinical Meetings (Business Wire)
08:30AM	Outset Medical to Report First Quarter 2023 Financial Results on Wednesday, May 3, 2023 (Business Wire)
Apr-03-23 07:01AM	Outset Medical (NASDAQ:OM) investors are sitting on a loss of 61% if they invested a year ago (Simply Wall St.)
Mar-25-23 08:26AM	There's More to the Mint Mobile Deal Than Ryan Reynolds (Motley Fool)
Feb-22-23 04:05PM	Outset Medical to Present at 43rd Annual Cowen Health Care Conference (Business Wire)
Feb-17-23 04:16PM	Outset Medical, Inc. (NASDAQ:OM) Q4 2022 Earnings Call Transcript (Insider Monkey)
Feb-15-23 05:54AM	Better Medtech Stock to Buy: InMode or Outset Medical? (Motley Fool) -6.06%
Feb-14-23 12:10PM	Why Shares of Outset Medical Are Down Tuesday (Motley Fool) -5.94%
Feb-13-23 05:45PM	Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Outset Medical Reports Fourth Quarter and Full Year 2022 Financial Results (Business Wire)
Feb-07-23 10:00AM	Computer Programs and Systems (CPSI) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release (Zacks)
Feb-06-23 10:00AM	Outset Medical, Inc. (OM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Jan-25-23 08:30AM	Outset Medical to Report Fourth Quarter and Full Year 2022 Financial Results on Monday, February 13, 2023 (Business Wire)
Jan-09-23 08:30AM	Outset Medical Reports Expected Fourth Quarter and Full Year 2022 Revenue, Provides 2023 Revenue and non-GAAP Gross Margin Guidance (Business Wire)
Jan-03-23 06:10PM	Why Outset Medical's Shares Rose 22.5% in December (Motley Fool)
Dec-23-22 05:20AM	Supercharged Returns: 2 Growth Stocks That Could Turn $1,000 Into $10,000 (Motley Fool)
Dec-22-22 11:21AM	Do You Think Outset Medical (OM) Has Low Growth Rates? (Insider Monkey)
Dec-20-22 04:05PM	Outset Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference (Business Wire)
Nov-28-22 08:00AM	Outset Medical to Present at the BofA Securities Home Care Conference (Business Wire) -6.37%
Nov-26-22 05:00AM	2 No-Brainer Stocks to Buy Now That Could Soar in 2023 (Motley Fool)
Nov-16-22 09:09AM	Outset Medical Ranked Number 33 Fastest-Growing Company in North America on the 2022 Deloitte Technology Fast 500 (Business Wire)
Nov-11-22 01:15PM	RBC Capital Initiates Coverage On This MedTech Stock Citing 'Differentiated Offering' (Benzinga)
Nov-09-22 07:24PM	2 Big Stock Winners From a Horrible Day on Wall Street (Motley Fool) +29.90%
04:05PM	Outset Medical to Present at Upcoming Investor Conferences (Business Wire)
Nov-08-22 06:25PM	Outset Medical, Inc. (OM) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -7.50%
04:05PM	Outset Medical Reports Third Quarter 2022 Financial Results (Business Wire)
Nov-04-22 08:30AM	Outset Medical Secures Up To $300 Million in Debt Financing (Business Wire)
Oct-27-22 09:00AM	Outset Medical Presenting Research on Human Factors Testing, Home Dialysis Patient Experience and More During ASN Kidney Week 2022 (Business Wire)
Oct-26-22 04:05PM	Outset Medical to Report Third Quarter 2022 Financial Results Tuesday, November 8, 2022 (Business Wire)
Oct-24-22 06:36AM	Outset Medical (NASDAQ:OM) shareholders have endured a 72% loss from investing in the stock a year ago (Simply Wall St.)
Sep-21-22 03:24AM	Change Healthcare (CHNG) Soars 6.4%: Is Further Upside Left in the Stock? (Zacks)
Aug-30-22 04:05PM	Outset Medical to Present at the 20th Annual Morgan Stanley Global Healthcare Conference (Business Wire)
Aug-15-22 09:00AM	Outset Medical Awarded VA Contract Aimed at Improving Dialysis Care for Veterans (Business Wire)
Aug-09-22 09:44AM	Why Outset Medical Is Worth a Look (Motley Fool)
Aug-04-22 06:27AM	Some Outset Medical, Inc. (NASDAQ:OM) Analysts Just Made A Major Cut To Next Year's Estimates (Simply Wall St.)
Aug-02-22 08:45AM	Outset Medical Stock Is Soaring: Here's Why Even Bigger Gains Could Be Ahead (Motley Fool)
Aug-01-22 11:15AM	Outset Medical, Inc. (OM) Reports Q2 Loss, Misses Revenue Estimates (Zacks) +26.93%
11:14AM	Outset Medical Shares Jump On Resuming Tablo Hemodialysis For Home Use (Benzinga)
10:02AM	Outset Medical Resumes Shipment of Tablo Systems for Home Use, Reports Second Quarter 2022 Financial Results and Provides 2022 Guidance (Business Wire)
Jul-28-22 09:44AM	Top 10 Stock Picks of Efrem Kamens Pura Vida Investments (Insider Monkey)
Jul-21-22 09:30AM	Jamie Dimon Tells It Like It Is as Earnings Season Kicks Off (Motley Fool) +5.84%
Jul-13-22 09:55AM	Does Outset Medical, Inc. (OM) Have the Potential to Rally 94% as Wall Street Analysts Expect? (Zacks)
Jun-24-22 05:10AM	Zacks Industry Outlook Highlights Omnicell, Axonics and Outset Medical (Zacks) +5.43%
Jun-14-22 03:12PM	Outset Medical Plunges on Shipment Hold: Buy the Stock on the Sell-Off? (Motley Fool) -34.05%
07:07AM	Why Outset Medical Shares Are Trading Lower Today (Benzinga)

Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Nash Marc	SVP Operations and R&D	Mar 15 '24	Sale	2.13	2,391	5,093	242,510	Mar 15 06:40 PM
Ahmed Nabeel	Chief Financial Officer	Mar 01 '24	Sale	3.15	1,584	4,990	322,877	Mar 04 04:34 PM
Trigg Leslie	Chair and CEO	Feb 15 '24	Sale	3.57	5,320	18,992	833,091	Feb 16 05:29 PM
Ahmed Nabeel	Chief Financial Officer	Feb 15 '24	Sale	3.57	4,403	15,719	312,594	Feb 16 05:24 PM
Brottem John L.	General Counsel	Feb 15 '24	Sale	3.57	3,341	11,927	245,046	Feb 16 05:26 PM
Williamson Steven S.	Chief Commercial Officer	Feb 15 '24	Sale	3.57	2,500	8,925	320,347	Feb 16 05:31 PM
Racine Jean-Olivier	Chief Technology Officer	Feb 15 '24	Sale	3.57	1,866	6,662	271,830	Feb 16 05:28 PM
Nash Marc	SVP Operations and R&D	Feb 15 '24	Sale	3.57	617	2,203	243,100	Feb 16 05:27 PM
Nash Marc	SVP Operations and R&D	Jan 16 '24	Sale	429.00	678	290,862	243,717	Jan 17 08:01 PM
Trigg Leslie	Chair and CEO	Jan 16 '24	Sale	4.29	8,126	34,861	838,411	Jan 17 08:03 PM
Ahmed Nabeel	Chief Financial Officer	Jan 16 '24	Sale	4.29	1,726	7,405	316,997	Jan 17 07:59 PM
Brottem John L.	General Counsel	Jan 16 '24	Sale	4.29	1,480	6,349	248,387	Jan 17 08:00 PM
Williamson Steven S.	Chief Commercial Officer	Jan 16 '24	Sale	4.29	996	4,273	322,847	Jan 17 08:04 PM
Porter Stacey L.	Chief People Officer	Jan 16 '24	Sale	4.29	768	3,295	61,448	Jan 17 08:02 PM
Racine Jean-Olivier	Chief Technology Officer	Jan 16 '24	Sale	4.29	723	3,102	273,696	Jan 17 08:03 PM
Trigg Leslie	Chair and CEO	Jan 08 '24	Sale	5.49	14,188	77,892	389,099	Jan 08 08:34 PM
Ahmed Nabeel	Chief Financial Officer	Jan 08 '24	Sale	5.49	10,709	58,792	76,819	Jan 08 08:29 PM
Brottem John L.	General Counsel	Jan 08 '24	Sale	5.49	7,344	40,319	48,807	Jan 08 08:30 PM
Williamson Steven S.	Chief Commercial Officer	Jan 08 '24	Sale	5.49	7,055	38,732	105,939	Jan 08 08:35 PM
Porter Stacey L.	Chief People Officer	Jan 08 '24	Sale	5.49	4,766	26,165	58,630	Jan 08 08:31 PM
Racine Jean-Olivier	Chief Technology Officer	Jan 08 '24	Sale	5.49	3,905	21,438	73,781	Jan 08 08:33 PM
Williamson Steven S.	Chief Commercial Officer	Nov 16 '23	Sale	4.76	3,584	17,060	112,994	Nov 17 04:22 PM
Trigg Leslie	Chair and CEO	Nov 16 '23	Sale	4.76	3,175	15,113	403,287	Nov 17 04:19 PM
Ahmed Nabeel	Chief Financial Officer	Nov 16 '23	Sale	4.76	1,643	7,821	87,528	Nov 17 04:08 PM
Brottem John L.	General Counsel	Nov 16 '23	Sale	4.76	1,431	6,812	56,151	Nov 17 04:15 PM
Racine Jean-Olivier	Chief Technology Officer	Nov 16 '23	Sale	4.76	790	3,760	77,686	Nov 17 04:18 PM
Porter Stacey L.	Chief People Officer	Nov 16 '23	Sale	4.76	671	3,194	63,396	Nov 17 04:17 PM
Nash Marc	SVP Operations and R&D	Nov 16 '23	Sale	4.76	562	2,675	44,757	Nov 17 04:15 PM
Ahmed Nabeel	Chief Financial Officer	Sep 01 '23	Sale	13.61	545	7,417	89,171	Sep 05 04:04 PM
Trigg Leslie	Chair and CEO	Aug 16 '23	Sale	15.10	3,028	45,723	406,461	Aug 17 04:41 PM
Ahmed Nabeel	Chief Financial Officer	Aug 16 '23	Sale	15.10	1,565	23,632	89,171	Aug 17 04:26 PM
Brottem John L.	General Counsel	Aug 16 '23	Sale	15.10	1,364	20,596	57,581	Aug 17 04:28 PM
Racine Jean-Olivier	Chief Technology Officer	Aug 16 '23	Sale	15.10	752	11,355	78,475	Aug 17 04:39 PM
Porter Stacey L.	Chief People Officer	Aug 16 '23	Sale	15.10	638	9,634	64,066	Aug 17 04:37 PM
Williamson Steven S.	Chief Commercial Officer	Aug 16 '23	Sale	15.10	635	9,588	116,577	Aug 17 04:43 PM
Nash Marc	SVP Operations and R&D	Aug 16 '23	Sale	15.10	535	8,078	44,998	Aug 17 04:34 PM
Trigg Leslie	Chair and CEO	Aug 01 '23	Option Exercise	4.11	20,000	82,200	429,489	Aug 03 04:11 PM
Trigg Leslie	Chair and CEO	Aug 01 '23	Sale	20.22	20,000	404,462	409,489	Aug 03 04:11 PM
Ahmed Nabeel	Chief Financial Officer	Aug 01 '23	Sale	20.07	990	19,869	90,736	Aug 03 04:10 PM
Brottem John L.	General Counsel	Jul 19 '23	Option Exercise	9.48	1,415	13,414	60,360	Jul 20 04:01 PM
Brottem John L.	General Counsel	Jul 19 '23	Sale	20.00	1,415	28,300	58,945	Jul 20 04:01 PM
Trigg Leslie	Chair and CEO	Jul 03 '23	Option Exercise	4.11	20,000	82,200	429,489	Jul 05 05:39 PM
Trigg Leslie	Chair and CEO	Jul 03 '23	Sale	20.90	20,000	417,944	409,489	Jul 05 05:39 PM
Ahmed Nabeel	Chief Financial Officer	Jul 03 '23	Sale	21.70	990	21,483	91,726	Jul 05 05:38 PM
Brottem John L.	General Counsel	Jun 20 '23	Option Exercise	9.48	1,414	13,405	60,359	Jun 21 04:01 PM
Brottem John L.	General Counsel	Jun 20 '23	Sale	21.97	1,414	31,066	58,945	Jun 21 04:01 PM
Trigg Leslie	Chair and CEO	Jun 01 '23	Option Exercise	4.11	20,000	82,200	429,489	Jun 01 06:08 PM
Trigg Leslie	Chair and CEO	Jun 01 '23	Sale	21.10	20,000	421,920	409,489	Jun 01 06:08 PM
Ahmed Nabeel	Chief Financial Officer	Jun 01 '23	Sale	20.83	990	20,622	92,716	Jun 01 05:31 PM
Brottem John L.	General Counsel	May 17 '23	Option Exercise	9.48	1,415	13,414	61,677	May 17 06:26 PM
Brottem John L.	General Counsel	May 17 '23	Sale	20.08	2,732	54,859	58,945	May 17 06:26 PM
Trigg Leslie	Chair and CEO	May 16 '23	Sale	19.91	2,962	58,973	409,489	May 16 08:30 PM
Ahmed Nabeel	Chief Financial Officer	May 16 '23	Sale	19.91	1,532	30,502	93,706	May 16 08:32 PM
Brottem John L.	General Counsel	May 16 '23	Sale	19.91	1,335	26,580	60,262	May 17 06:26 PM
Racine Jean-Olivier	Chief Technology Officer	May 16 '23	Sale	19.91	735	14,634	79,227	May 16 08:35 PM
Williamson Steven S.	Chief Commercial Officer	May 16 '23	Sale	19.91	681	13,559	117,212	May 16 08:28 PM
Porter Stacey L.	Chief People Officer	May 16 '23	Sale	19.91	626	12,464	64,704	May 16 08:34 PM
Williamson Steven S.	Chief Commercial Officer	May 08 '23	Sale	19.83	10,000	198,300	117,893	May 08 05:59 PM
Trigg Leslie	Chair and CEO	May 03 '23	Option Exercise	4.05	40,000	161,983	432,451	May 05 06:11 PM
Brottem John L.	General Counsel	May 03 '23	Option Exercise	9.48	1,414	13,405	63,011	May 05 06:13 PM
Trigg Leslie	Chair and CEO	May 03 '23	Sale	20.00	40,000	800,180	412,451	May 05 06:11 PM
Brottem John L.	General Counsel	May 03 '23	Sale	20.00	1,414	28,280	61,597	May 05 06:13 PM
Ahmed Nabeel	Chief Financial Officer	May 03 '23	Sale	20.00	990	19,800	95,238	May 05 06:16 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

OFIX

Orthofix Medical Inc

OM

Outset Medical Inc

Upgrade your FINVIZ experience